FDA authorizes Pfizer or Moderna booster for all adults; CDC advisory panel recommends the booster for all adults
The Food and Drug Administration today authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at least six months after receiving the initial two-dose series or two months after receiving the single-dose Johnson & Johnson vaccine.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices then recommended a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older, based on individual benefit and risk, at least six months after receiving the initial two-dose series. The CDC director will now consider that recommendation.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…